NICU-TECH RM9L-RS Probe ME Feasibility Study

Sponsor
GE Healthcare (Industry)
Overall Status
Terminated
CT.gov ID
NCT01181596
Collaborator
(none)
31
1
17
1.8

Study Details

Study Description

Brief Summary

Use of a new ultrasound device designed for babies to look at the catheters in veins and arteries as well as the blood vessel itself. An observational study to assess the the clinicians perception of the ultrasound image quality as a tool to detect catheters in vessels.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The intent of the study is to confirm the maximum penetration of the NICU-Tech RM9L-RS probe. The investigators collected images on patients with PIV (Peripheral Intra Venous)/PAC (Peripheral Arterial Catheter) and central line catheters. The investigators collected images of deep vessel structures for offline processing to improve NICU-Tech algorithms for vessel segmentation.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    31 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    NICU-TECH RM9L-RS Probe ME Feasibility Study
    Study Start Date :
    Jun 1, 2010
    Actual Primary Completion Date :
    Nov 1, 2011
    Actual Study Completion Date :
    Nov 1, 2011

    Arms and Interventions

    Arm Intervention/Treatment
    Arm 1: observational ultrasound

    Collection of image data with the ultrasound probe.

    Outcome Measures

    Primary Outcome Measures

    1. Participants That Fulfilled All Study Procedures. [1 day (day of procedure)]

      Acquisition of basic images and video were obtained from study participants who already have one or more catheters in place.

    2. Vessel Penetration of NICU-Tech RM9L-RS Probe [1 day (day of procedure)]

      The algorithmic depth of vessel penetration will be collected.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    23 Weeks to 6 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Neonates that are 23 gestational weeks at birth (and greater than 500 grams) to a 6 month old born infant at term (maximum weight 7 kg) who already have one or more lines placed (PIV/PAC/UVC/UACs/PICC) as part of their medical care. NO INFANT WILL HAVE A LINE PLACE FOR THE PURPOSE OF THIS STUDY
    Exclusion Criteria:
    • Neonates that are less than 23 gestational weeks at birth

    • Neonates that are 23 gestational weeks at birth but are less than 500 grams in weight

    • Patients weighing more than 7 kg.-Patients older than 6 months

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UCSD Medical Center San Diego California United States 92103

    Sponsors and Collaborators

    • GE Healthcare

    Investigators

    • Principal Investigator: Jae Kim, MD, UCSD Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    GE Healthcare
    ClinicalTrials.gov Identifier:
    NCT01181596
    Other Study ID Numbers:
    • NICU-TECH RM9L-RS
    First Posted:
    Aug 13, 2010
    Last Update Posted:
    Aug 6, 2019
    Last Verified:
    Jun 1, 2019

    Study Results

    Participant Flow

    Recruitment Details This is an observational study where recruitment took place in the Neonatal Intensive Care Unit. Enrollment period of June 2010 - November 2011.
    Pre-assignment Detail If participants health worsens prior to assignment they were excluded from the study.
    Arm/Group Title Ultrasound Probing
    Arm/Group Description Ultrasound probing to guide catheter placement
    Period Title: Overall Study
    STARTED 31
    COMPLETED 31
    NOT COMPLETED 0

    Baseline Characteristics

    Arm/Group Title Ultrasound Probing
    Arm/Group Description Ultrasound probing to guide catheter placement
    Overall Participants 31
    Age (Count of Participants)
    <=18 years
    31
    100%
    Between 18 and 65 years
    0
    0%
    >=65 years
    0
    0%
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    0.5
    (.02)
    Sex: Female, Male (Count of Participants)
    Female
    15
    48.4%
    Male
    16
    51.6%

    Outcome Measures

    1. Primary Outcome
    Title Participants That Fulfilled All Study Procedures.
    Description Acquisition of basic images and video were obtained from study participants who already have one or more catheters in place.
    Time Frame 1 day (day of procedure)

    Outcome Measure Data

    Analysis Population Description
    Study participants who have one or more catheters in place.
    Arm/Group Title Arm 1: Observational Ultrasound
    Arm/Group Description Collection of image data with the ultrasound probe.
    Measure Participants 31
    Count of Participants [Participants]
    31
    100%
    2. Primary Outcome
    Title Vessel Penetration of NICU-Tech RM9L-RS Probe
    Description The algorithmic depth of vessel penetration will be collected.
    Time Frame 1 day (day of procedure)

    Outcome Measure Data

    Analysis Population Description
    Images were not adequate to visualize catheter penetration, or to obtain measurements.
    Arm/Group Title Ultrasound Probing
    Arm/Group Description Ultrasound probing to guide catheter placement
    Measure Participants 0

    Adverse Events

    Time Frame 1.5 years
    Adverse Event Reporting Description
    Arm/Group Title Ultrasound Probing
    Arm/Group Description Ultrasound probing to guide catheter placement
    All Cause Mortality
    Ultrasound Probing
    Affected / at Risk (%) # Events
    Total 0/31 (0%)
    Serious Adverse Events
    Ultrasound Probing
    Affected / at Risk (%) # Events
    Total 0/31 (0%)
    Other (Not Including Serious) Adverse Events
    Ultrasound Probing
    Affected / at Risk (%) # Events
    Total 0/31 (0%)

    Limitations/Caveats

    Enrollment was stopped early/terminated, study development stopped and no results were analyzed.

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.

    Results Point of Contact

    Name/Title Jae Kim, MD
    Organization University of California - San Diego
    Phone 619-543-3759
    Email neojae@ucsd.edu
    Responsible Party:
    GE Healthcare
    ClinicalTrials.gov Identifier:
    NCT01181596
    Other Study ID Numbers:
    • NICU-TECH RM9L-RS
    First Posted:
    Aug 13, 2010
    Last Update Posted:
    Aug 6, 2019
    Last Verified:
    Jun 1, 2019